BASF to begin squeeze-out process for Pronova, plans to finalize deal in first quarter

BASF announced today that its cash offer to shareholders of Pronova BioPharma (Lysaker, Norway), which ended on 18 January 2013, resulted in 293,975,655 Pronova shares being tendered. This corresponds to 97.7% of all Pronova shares. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be almost 5 billion Norwegian kroner ($892.4 million). BASF says that all regulatory approvals required for completion of the voluntary offer have been obtained.   The next step in the acquisition process...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers